MC38-hCD24/hPD-L1
Strain Information
Validation Data
Fig.1 CD24 and PD-L1 expression in MC38-hCD24/hPD-L1 cell line
Fig.2 Tumor growth curve of MC38-hCD24/hPD-L1 syngeneic model
Fig.3 Body weight change of MC38-hCD24/hPD-L1 syngeneic model
Fig.4 The expression of hCD24 and hPD-L1 in humanized modified tumors by FACS
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreOur vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
Learn more